President and Chief Financial Officer
Lee Kalowski is president and chief financial officer of Bicycle Therapeutics.
Prior to joining Bicycle, Lee served as the chief financial officer of Tokai Pharmaceuticals, Inc., where he helped lead the company’s $105 million initial public offering in 2014. Previously, he was vice president, global biotechnology equity research at Credit Suisse, where he served as a senior research analyst covering the biotechnology sector. Before that, Lee worked in mergers and acquisitions in the pharmaceutical division of Johnson & Johnson and in global pharmaceutical equity research at Sanford C. Bernstein and Prudential Equity Group.
Lee received a B.A. in biology and economics from Union College and an MBA from the Wharton School of the University of Pennsylvania.